Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells

Fig. 1

Low galectin-3 (Gal3) expression correlates with poor outcome in node-positive breast cancer. a Representative pictures of IHC staining for Gal3 in TMAs with examples for Gal3 high (upper panel) and Gal3 low (lower panel). b Tumor microarrays (TMA) of node-positive breast cancer patients were stained for Gal3. High Gal3 expression shows better locoregional relapse-free (LRRF) survival (left panel), better disease-specific survival (DSS) (middle panel) as well as better overall survival (OS) (right panel) than low Gal3 expression in node-positive breast cancer

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us